Literature DB >> 28893369

Virulence determinants of Moraxella catarrhalis: distribution and considerations for vaccine development.

Luke V Blakeway1, Aimee Tan1, Ian R A Peak1,2, Kate L Seib1.   

Abstract

Moraxella catarrhalis is a human-restricted opportunistic bacterial pathogen of the respiratory mucosa. It frequently colonizes the nasopharynx asymptomatically, but is also an important causative agent of otitis media (OM) in children, and plays a significant role in acute exacerbations of chronic obstructive pulmonary disease (COPD) in adults. As the current treatment options for M. catarrhalis infection in OM and exacerbations of COPD are often ineffective, the development of an efficacious vaccine is warranted. However, no vaccine candidates for M. catarrhalis have progressed to clinical trials, and information regarding the distribution of M. catarrhalis virulence factors and vaccine candidates is inconsistent in the literature. It is largely unknown if virulence is associated with particular strains or subpopulations of M. catarrhalis, or if differences in clinical manifestation can be attributed to the heterogeneous expression of specific M. catarrhalis virulence factors in the circulating population. Further investigation of the distribution of M. catarrhalis virulence factors in the context of carriage and disease is required so that vaccine development may be targeted at relevant antigens that are conserved among disease-causing strains. The challenge of determining which of the proposed M. catarrhalis virulence factors are relevant to human disease is amplified by the lack of a standardized M. catarrhalis typing system to facilitate direct comparisons of worldwide isolates. Here we summarize and evaluate proposed relationships between M. catarrhalis subpopulations and specific virulence factors in the context of colonization and disease, as well as the current methods used to infer these associations.

Entities:  

Keywords:  Moraxella catarrhalis; chronic obstructive pulmonary disease; otitis media; phase variation; vaccine; virulence factors

Mesh:

Substances:

Year:  2017        PMID: 28893369     DOI: 10.1099/mic.0.000523

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  13 in total

1.  Persistence of Moraxella catarrhalis in Chronic Obstructive Pulmonary Disease and Regulation of the Hag/MID Adhesin.

Authors:  Timothy F Murphy; Aimee L Brauer; Melinda M Pettigrew; Eric R LaFontaine; Hervé Tettelin
Journal:  J Infect Dis       Date:  2019-04-16       Impact factor: 5.226

Review 2.  Panel 8: Vaccines and immunology.

Authors:  Mark R Alderson; Tim Murphy; Stephen I Pelton; Laura A Novotny; Laura L Hammitt; Arwa Kurabi; Jian-Dong Li; Ruth B Thornton; Lea-Ann S Kirkham
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2019-12-18       Impact factor: 1.675

3.  The microbiome in PTEN hamartoma tumor syndrome.

Authors:  Victoria Byrd; Ted Getz; Roshan Padmanabhan; Hans Arora; Charis Eng
Journal:  Endocr Relat Cancer       Date:  2017-12-12       Impact factor: 5.678

4.  Virulence factors of Moraxella catarrhalis outer membrane vesicles are major targets for cross-reactive antibodies and have adapted during evolution.

Authors:  Daria Augustyniak; Rafał Seredyński; Siobhán McClean; Justyna Roszkowiak; Bartosz Roszniowski; Darren L Smith; Zuzanna Drulis-Kawa; Paweł Mackiewicz
Journal:  Sci Rep       Date:  2018-03-21       Impact factor: 4.379

5.  Moraxella catarrhalis phase-variable loci show differences in expression during conditions relevant to disease.

Authors:  Aimee Tan; Luke V Blakeway; Yuedong Yang; Yaoqi Zhou; John M Atack; Ian R Peak; Kate L Seib
Journal:  PLoS One       Date:  2020-06-18       Impact factor: 3.240

6.  Moraxella catarrhalis NucM is an entry nuclease involved in extracellular DNA and RNA degradation, cell competence and biofilm scaffolding.

Authors:  Aimee Tan; Wing-Sze Li; Anthony D Verderosa; Luke V Blakeway; Tsitsi D Mubaiwa; Makrina Totsika; Kate L Seib
Journal:  Sci Rep       Date:  2019-02-22       Impact factor: 4.379

7.  The Moraxella catarrhalis phase-variable DNA methyltransferase ModM3 is an epigenetic regulator that affects bacterial survival in an in vivo model of otitis media.

Authors:  Luke V Blakeway; Aimee Tan; Joseph A Jurcisek; Lauren O Bakaletz; John M Atack; Ian R Peak; Kate L Seib
Journal:  BMC Microbiol       Date:  2019-12-09       Impact factor: 3.605

8.  Co-carriage of Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis among three different age categories of children in Hungary.

Authors:  Eszter Kovács; Judit Sahin-Tóth; Adrienn Tóthpál; Mark van der Linden; Tamás Tirczka; Orsolya Dobay
Journal:  PLoS One       Date:  2020-02-07       Impact factor: 3.240

9.  Moraxella catarrhalis Restriction-Modification Systems Are Associated with Phylogenetic Lineage and Disease.

Authors:  Luke V Blakeway; Aimee Tan; Rachael Lappan; Amir Ariff; Janessa L Pickering; Christopher S Peacock; Christopher C Blyth; Charlene M Kahler; Barbara J Chang; Deborah Lehmann; Lea-Ann S Kirkham; Timothy F Murphy; Michael P Jennings; Lauren O Bakaletz; John M Atack; Ian R Peak; Kate L Seib
Journal:  Genome Biol Evol       Date:  2018-11-01       Impact factor: 3.416

Review 10.  Immunogenicity of trimeric autotransporter adhesins and their potential as vaccine targets.

Authors:  Arno Thibau; Alexander A Dichter; Diana J Vaca; Dirk Linke; Adrian Goldman; Volkhard A J Kempf
Journal:  Med Microbiol Immunol       Date:  2019-12-01       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.